These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 33530913)
1. Cluster Analysis of Coronavirus Sequences using Computational Sequence Descriptors: With Applications to SARS, MERS and SARS-CoV-2 (CoVID-19). Vračko M; Basak SC; Dey T; Nandy A Curr Comput Aided Drug Des; 2021; 17(7):936-945. PubMed ID: 33530913 [TBL] [Abstract][Full Text] [Related]
2. Clustering of Zika Viruses Originating from Different Geographical Regions using Computational Sequence Descriptors. Vračko M; Basak SC; Sen D; Nandy A Curr Comput Aided Drug Des; 2021; 17(2):314-322. PubMed ID: 31878862 [TBL] [Abstract][Full Text] [Related]
3. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
4. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
5. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]. Lvov DK; Alkhovsky SV Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561 [TBL] [Abstract][Full Text] [Related]
6. Genomic characterization and phylogenetic evolution of the SARS-CoV-2. Zhang RH; Ai X; Liu Y; Li CH; Zhang HL Acta Virol; 2020; 64(4):496-500. PubMed ID: 32985209 [TBL] [Abstract][Full Text] [Related]
11. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual. Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601 [TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19. Jha PK; Vijay A; Halu A; Uchida S; Aikawa M Front Cardiovasc Med; 2020; 7():623012. PubMed ID: 33521069 [TBL] [Abstract][Full Text] [Related]
13. Patents Related to Pathogenic Human Coronaviruses. Dos Santos M; Ferreira AVF; da Silva JO; Nogueira LM; Machado JM; Francisco MFC; da Paz MC; Giunchetti RC; Galdino AS Recent Pat Biotechnol; 2021; 15(1):12-24. PubMed ID: 33504319 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan. Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267 [TBL] [Abstract][Full Text] [Related]
15. Coronaviruses - a new old menace. Golke A; Piekarska K; Dzieciątkowski T Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077 [TBL] [Abstract][Full Text] [Related]
16. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Sharma HN; Latimore COD; Matthews QL Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578250 [TBL] [Abstract][Full Text] [Related]
17. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities. Arisan ED; Dart A; Grant GH; Arisan S; Cuhadaroglu S; Lange S; Uysal-Onganer P Viruses; 2020 Jun; 12(6):. PubMed ID: 32512929 [TBL] [Abstract][Full Text] [Related]
18. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]. Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715 [TBL] [Abstract][Full Text] [Related]
19. Recent Patents and Advances on Nanotechnologies against Coronavirus. Abedini-Nassab R; Mahdaviyan N Recent Pat Nanotechnol; 2021; 15(4):322-330. PubMed ID: 33172382 [TBL] [Abstract][Full Text] [Related]
20. Management of epigenomic networks entailed in coronavirus infections and COVID-19. El Baba R; Herbein G Clin Epigenetics; 2020 Aug; 12(1):118. PubMed ID: 32758273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]